Healthstream's 2026 Q2 Earnings Call: Revenue Catch-Up Clarity, Legacy Decline Discrepancies, and Growth Metric Confusion

Date of Call: Aug 4, 2026

Financials Results

• Revenue: $83.7M, up 12.5% YOY
• EPS: $0.23 per diluted share, up from $0.18 prior year
• Gross Margin: 65.3%, compared to 64.6% in the prior year quarter

Guidance:

• Revenue for full year 2026 expected to be between $327M and $332M (growth of 7.5% to 9.2% over 2025).
• Net income expected to be between $19.5M and $22.2M.
• Adjusted EBITDA expected to be between $74M and $78M.
• Capital expenditures expected to be between $31M and $34M.
• Revenue growth rate for Q3 expected to be approximately 8%.
• Adjusted EBITDA margin expected to approximate 22% for Q3.

Business Commentary:

Record Financial Performance:

• Healthstream reported record revenues of $83.7 million for Q2 2026, up 12.5% year-over-year, and record adjusted EBITDA of $20.6 million, up 16.9% year-over-year.
• The strong financial growth was driven by successful execution, increased customer adoption of their solutions, and strategic investments in career networks.

Career Network Investment:

• Healthstream's career network applications, such as My Clinical Exchange, grew 29% in the quarter compared to the same period last year.
• The growth resulted from investments in personnel with 15 new positions added to develop career networks, enabling the company to help healthcare organizations find qualified employees and improve staffing solutions.

Product Bundling and Market Strategy:

• The competency suite saw a revenue increase of approximately 12% over the previous year, and there was uptake in market bundles for skilled nursing, long-term care, and critical access hospitals.
• This trend is attributed to Healthstream's bundling strategy, which simplifies purchasing decisions and offers more complete solutions, thereby enhancing customer value and driving growth.

Platform and AI Integration:

• Insights, the reporting layer of Healthstream's H-DREAM platform, saw active users grow from 100 to over 2,600 in its first full year.
• The growth is due to the integration of data from seven applications into a unified data lake, allowing for advanced analytics and AI-driven insights, which enhances the platform's value for customers.

Cybersecurity Incident Disclosure:

• Healthstream disclosed a cybersecurity incident in an 8K filing, with investigations ongoing.
• The company stated that customer-facing systems were not accessed or compromised, and no financial material impact is anticipated.

Sentiment Analysis:

Overall Tone: Positive

• CEO stated 'We do have a lot to discuss, as always, and it's fun when we can start with strong financial growth.' and 'We believe these investments...will help broaden our reach into health care and help us deliver long-term growth in the future.' CFO highlighted 'record-setting revenues' and 'record-setting adjusted EBITDA' with significant percentage growth.

Q&A:

• Question from Matt Hewitt (Craig Hallam): What's driving the competitive wins across the portfolio? Is it a heightened focus by customers to get to 'one throat to choke,' or because you have a better platform versus a legacy platform?
  Response: The wins are driven by a bundling strategy that offers more complete solutions with better unit pricing, the advancing platform capabilities (like Insights reporting), and curating market-specific bundles for different healthcare settings.

• Question from Matt Hewitt (Craig Hallam): Where do you sit from a penetration standpoint in the long-term care market, and where do you see that as a driver or opportunity?
  Response: Healthstream has a footprint in long-term care, skilled nursing, and home health. The company is seeing traction in skilled nursing and critical access hospitals, with market bundles helping. The 12.6 million healthcare workers across all settings present a large total addressable market.

• Question from Dustin (on behalf of Ryan, firm not specified): Regarding your guidance update, does it now include the $2 million catch-up, or was that previously in the guide?
  Response: The $2 million revenue catch-up in Q2 was incremental to previous expectations and has now flowed through the updated full-year revenue guidance. It had a meaningful impact on Q2 profitability.

• Question from Richard Close (Canaccord Genuity): Could you clarify the legacy revenue impact in the quarter?
  Response: Legacy credentialing and scheduling product revenues, excluding the $2 million catch-up, were $7.4M in Q2, down $1.3M or 15% compared to the prior year quarter.

• Question from Richard Close (Canaccord Genuity): Could you put the larger contract values ($10M, $5M, etc.) in perspective? Are they different in terms of contract lengths, and what is the annualized revenue?
  Response: These are larger bundles over longer periods (typically 4 years or more), representing total contract value. Revenue recognition timing and gross margin vary by bundle content (e.g., resuscitation suites have lower margin due to royalties). Bundles simplify customer decisions and are expected to improve renewal rates.

• Question from Richard Close (Canaccord Genuity): When you mentioned Credential Stream sales up 14% in the second quarter, is that new bookings or revenue? And is the 14% year-over-year growth?
  Response: The 14% growth refers to year-over-year revenue from implementations, not new bookings. It indicates contract go-lives adding to the product's total revenue.

• Question from Richard Close (Canaccord Genuity): With respect to Shift Wizard and larger system go-lives, is the product now ready for prime time in these larger accounts?
  Response: Healthstream is feeling better about Shift Wizard's ability to scale within complex, multi-facility health systems, reflecting improved capabilities and successful implementations, though it may not yet be in 'prime time' for the largest systems.

• Question from Richard Close (Canaccord Genuity): With respect to Insights and the data lake, is that a revenue contributor? What's the revenue model?
  Response: Insights offers a revenue model with buy-ups (Insights Plus, advanced analytics tools). It allows customers to analyze data across multiple applications, enhancing Healthstream's platform value, lowering refactoring costs, and generating additional revenue.

• Question from Vincent (Barrington Research): How is the payer side in the credentialing business performing, and what's the pipeline look like?
  Response: The payer side has seen good wins, with larger and bigger contracts, though they take longer to develop. There is a pipeline with another targeted win in the second half of the year, and the acquisition of Versus 12 has strengthened positioning.

• Question from Vincent (Barrington Research): How are price accelerators taking hold? Any pushback?
  Response: Price accelerators are now a standard part of renewals for core products, rolled out over two years. The market is accepting of them as they help customers budget better and avoid large, sudden price jumps at contract ends.

Contradiction Point 1

Financial Impact and Treatment of the $2M Revenue Catch-up

Contradiction on whether the $2M catch-up was included in prior guidance.

Dustin (for Ryan) (Canaccord Genuity) - Dustin (for Ryan) (Canaccord Genuity)

2026Q2: The $2 million revenue catch-up in Q2 was incremental to previous expectations and has now been flowed through into the updated full-year revenue guidance. - Scotty Roberts(CFO)

Does your updated guidance now include the $2 million catch-up, or was it already part of the previous guidance? - Dustin (for Ryan) (Canaccord Genuity)

2026Q2: The $2 million catch-up was incremental to previous expectations and is now included in the updated full-year revenue guidance. - Scotty Roberts(CFO)

Contradiction Point 2

Presentation of Growth Metrics for CredentialStream and ShiftWizard

Contradiction on whether growth rates refer to bookings or revenue.

Richard Close (Canaccord Genuity) - Richard Close (Canaccord Genuity)

2026Q2: The 14% growth for Credential Stream and the 30% growth for ShiftWizard both refer to year-over-year revenue growth, not new bookings. - Robert A. Frist, Jr.(CEO) & Scotty Roberts(CFO)

Are larger systems like Shift Blizzard now achieving success and readiness for prime time in larger accounts, as previously questioned? - Richard Close (Canaccord Genuity)

2026Q2: The growth rates (14% for CredentialStream, 30% for ShiftWizard) are for revenue year-over-year, not new bookings. - Robert A. Frist Jr.(CEO) & Scotty Roberts(CFO)

Contradiction Point 3

Legacy Revenue Decline

Inconsistent year-over-year decline rate for legacy product revenue.

Richard Close (Canaccord Genuity) - Richard Close (Canaccord Genuity)

2026Q2: Revenues from legacy credentialing and scheduling products... were $7.4 million in Q2, down $1.3 million (15%) year-over-year... - Scotty Roberts(CFO)

Was the legacy revenue impact discussed in the quarter? - Richard Close (Canaccord Genuity)

2026Q1: Revenue from legacy applications in Q1 was $7.6 million, down 16% from Q1 last year. - Scotty Roberts(CFO)

Contradiction Point 4

Market-Specific Bundles Uptake

Contradiction on whether revenue growth is strong or developing for specific market bundles.

Matt Hewitt (Craig Hallam) - Matt Hewitt (Craig Hallam)

2026Q2: Market bundles are being developed for skilled nursing, long-term care, and home health. While specific penetration numbers aren't provided... - Robert A. Frist, Jr.(CEO)

What is your current market penetration in the long-term care sector, and how do you view it as a growth opportunity moving forward? - Vincent Colicchio (Barrington Research)

2026Q1: ...revenue growth is stronger in the mid-market and above (driven by the Competency Suite and Resuscitation Suite), the small hospital market is important for building the ecosystem... - Robert Frist(CEO)

Contradiction Point 5

Legacy Revenue Contribution and Transition Status

Contradiction on the magnitude and status of legacy revenue.

Richard Close (Canaccord Genuity) - Richard Close (Canaccord Genuity)

2026Q2: Revenues from legacy credentialing and scheduling products... were $7.4 million in Q2, down $1.3 million (15%) year-over-year... - Scotty Roberts(CFO)

Did you discuss the legacy revenue impact in the quarter? - Constantine Davides (Citizens)

20260224-2025 Q4: Overall, legacy revenue across the company is approximately 10% of total revenue (~$30 million). - Robert Frist(CEO)